US FDA Approves Biocon’s Insulin Glargine Injection Semglee
The US Food and Drug Administration has approved Biocon Biologics India Ltd’s insulin glargine injection Semglee for controlling high blood sugar in adults with diabetes, the company said. Semglee,...